SCHEMBL4347979

SCHEMBL4347979

CCC/C=C1/SC(N2CCOCC2)=NC1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.54
ALDH1A1 P00352 8/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
MAPT P10636 10/20 0.53
SMN1; SMN2 Q16637 6/20 0.53
RAB9A P51151 5/20 0.53
HPGD P15428 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
NPC1 O15118 2/20 0.51
HCRTR1 O43613 1/20 0.51
LMNA P02545 4/20 0.48
PSMD14 O00487 1/20 0.48
POLB P06746 2/20 0.46
GPR55 Q9Y2T6 1/20 0.46
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347983 1.00 RECQL (0.54) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4355577 0.91 RECQL (0.51) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4355576 0.91 RECQL (0.51) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4354151 0.90 RECQL (0.50) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4357375 0.90 RECQL (0.50) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4354148 0.90 RECQL (0.50) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4357371 0.90 RECQL (0.50) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL13750894 0.90 RECQL (0.50) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4348814 0.82 ALDH1A1 (0.52) RECQLALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4348817 0.82 ALDH1A1 (0.52) RECQLALDH1A1CYP1A2CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP claimed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP disclosed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 RECQL 3220/4885ALDH1A1 284/4885CYP1A2 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.